Immunosuppressive Agents: all 5,940 studies that test it
Page 43 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Effect of Switching to Certican® in Viremia of Hepatitis C Virus in Adult Renal Allograft RecipientsCompletedNCT01469884Phase 4
- Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic MetastasesCompletedNCT01469572Phase 1
- Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk NeuroblastomaCompletedNCT01467986Phase 2
- Everolimus in Refractory Testicular Germ Cell CancerCompletedNCT01466231Phase 2
- International Pleuropulmonary Blastoma (PPB) Treatment and Biology RegistryActive, not recruitingNCT01464606Not applicable
- Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell CancerCompletedNCT01462214Phase 1/2
- Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT01462006Not applicable
- Sequential Treatment of CD20-positive Posttransplant Lymphoproliferative Disorder (PTLD)TerminatedNCT01458548Phase 2
- Study to Evaluate the Safety and Efficacy of Switching Calcineurin Inhibitor to Everolimus After Kidney Transplantation in AdultsStatus unknownNCT01455649Phase 4
- Everolimus in Combination With DHAP in Patients With Relapsed or Refractory Hodgkin LymphomaCompletedNCT01453504Phase 1/2
- Phase 1 Study to Evaluate the PK, Safety, and Tolerability of BG00012 in Chinese, Japanese, and Caucasian Healthy VolunteersCompletedNCT01453426Phase 1
- Tanshinone in Polycystic Ovary SyndromeStatus unknownNCT01452477Not applicable
- The Efficacy and Safety of Tacrolimus in Treated Refractory Focal Segmental GlomerulosclerosisTerminatedNCT01451489Not applicable
- A Study to Investigate How JNJ-38518168 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis ParticipantsCompletedNCT01450982Phase 1
- Clinical Study Comparing the New Immunosuppressive Drug Gusperimus With the Conventional Treatment in Wegener's GranulomatosisTerminatedNCT01446211Phase 3
- ABT-888 Plus Metronomic Cyclophosphamide to Treat CancerCompletedNCT01445522Phase 1
- A Study to Investigate How JNJ-39758979 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis ParticipantsCompletedNCT01442545Phase 1
- A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.WithdrawnNCT01440361Phase 2
- Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma (PSHCI 10-011)Status unknownNCT01439750Phase 1
- Continuous Intraventricular Methotrexate in Treating Patients With Leptomeningeal DiseaseWithdrawnNCT01438021Not applicable
- Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected MelanomaCompletedNCT01435499Phase 1
- AADAPT - Analysis of Advagraf Dose Adaptation Post TransplantationCompletedNCT01435291Phase 4
- Safety and Pharmacokinetic Characteristics of HD203 Liq. in Healthy SubjectsCompletedNCT01431404Phase 1
- Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss PatientsCompletedNCT01430572Phase 1
- A Study to Assess the Bioavailability of ASP015KCompletedNCT01430078Phase 1
- Pharmacokinetic Interaction Study to Assess the Effect of ASP015K on Tacrolimus in Healthy VolunteersCompletedNCT01430065Phase 1
- Tacrolimus Versus Cyclosporine for Immunosuppression After Lung TransplantationCompletedNCT01429844Phase 3
- Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis RegimensActive, not recruitingNCT01428973Phase 2
- Exploration of TNF-alpha Blockade With Golimumab in the Induction of Clinical Remission in Patients With Early Peripheral Spondyloarthritis (SpA) According to ASAS-criteriaCompletedNCT01426815Phase 3
- Dasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib MesylateTerminatedNCT01426334Phase 1
- Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic LeukaemiaStatus unknownNCT01423747Phase 3
- Everolimus in de Novo Liver Transplantation: a Multicentre Randomized StudyStatus unknownNCT01423708Phase 2
- ALL-SCT BFM International- HSCT in Children and Adolescents With ALLStatus unknownNCT01423500Phase 3
- Fingolimod -Response According to Coping - EvaluationCompletedNCT01420055Phase 4
- Rectal Tacrolimus in the Treatment of Resistant Ulcerative ProctitisCompletedNCT01418131Phase 4
- Consolidation Therapy With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 in Patients With Chronic Lymphocytic Leukemia Following Upfront Chemotherapy With Pentostatin, Cyclophosphamide and RituximabCompletedNCT01416974Phase 1
- Use of RAD001 as Monotherapy in the Treatment of Neurofibromatosis 1 Related Internal Plexiform NeurofibromasCompletedNCT01412892Phase 2
- A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's SarcomaTerminatedNCT01412515Phase 2
- Advagraf/Prograf Conversion TrialCompletedNCT01410162Phase 4
- Rotating Pazopanib and Everolimus to Avoid ResistanceCompletedNCT01408004Phase 2
- A Study to Assess the Pharmacokinetics of ASP015K in Healthy Male SubjectsCompletedNCT01406132Phase 1
- Efficacy of Certican® in Combination With Myfortic® in RenalStatus unknownNCT01399242Phase 4
- Cyclophosphamide and Pulse Dexamethasone With Rapamycin or HydroxychloroquineCompletedNCT01396200Early Phase 1
- Comparison of Two Etanercept Regimens (REUMATOCEPT® Versus ENBREL®) for Treatment of Rheumatoid ArthritisWithdrawnNCT01394913Phase 3
- Steroids and Azathioprine in Advanced IgANCompletedNCT01392833Phase 3
- Clinical Trial of 0.0003% Calcitriol, 0.1% Tacrolimus, and Petrolatum for the Treatment of Pityriasis AlbaCompletedNCT01388517Phase 4
- Irinotecan, Cetuximab and Everolimus to Patients With Metastatic Colorectal CancerCompletedNCT01387880Phase 2
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015KCompletedNCT01387087Phase 1
- Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung CancerWithdrawnNCT01383668Phase 1
- Phase I Study of GSK1550188 in Japanese Subjects With Systemic Lupus Erythematosus (SLE)CompletedNCT01381536Phase 1
- The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBCStatus unknownNCT01378533Phase 3
- Allogenic Haematopoietic Cell Transplantation for Patients With Refractory "Triple Negative" Breast CancerTerminatedNCT01375023Phase 2
- Efficacy of Sirolimus In Liver Transplantation for Hepatocellular Carcinoma (HCC)CompletedNCT01374750Phase 2
- Etanercept Treating Patient With Acute ST Segment Elevated Myocardial InfarctionStatus unknownNCT01372930Phase 4
- A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft RecipientsTerminatedNCT01371344Phase 4
- A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ TransplantationCompletedNCT01371331Phase 4
- Intensified Rituimab Prephase Before FCR in Untreated B-CLLCompletedNCT01370772Phase 2
- Single Dose Study Of The Effect Of Cyclosporine On The Pharmacokinetics Of PF-04991532 In Health VolunteersCompletedNCT01370343Phase 1
- Pharmacokinetic Interaction Study to Assess the Effect of ASP015K on Mycophenolate Mofetil in Healthy VolunteersCompletedNCT01364987Phase 1
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015KCompletedNCT01364974Phase 1
- A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.CompletedNCT01363752Phase 4
- A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)CompletedNCT01362153Phase 1
- TAC Versus TCX as Adjuvant Treatment for High-risk Her2-Negative Breast CancerCompletedNCT01354522Phase 3
- Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium MycophenolateCompletedNCT01354301Phase 4
- Revlimid, Endoxan, Prednison Evaluation After Prior Revlimid Treatment (REPEAT)CompletedNCT01352338Phase 1/2
- Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast CancerActive, not recruitingNCT01351909Phase 1
- BIBF 1120 and RAD001 in Solid Tumors - Phase ICompletedNCT01349296Phase 1
- Extension Study of Tocilizumab Long Term Treatment of Moderate to Severe Rheumatoid Arthritis PatientsCompletedNCT01347983Phase 3
- Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma PatientsCompletedNCT01346787Phase 2
- Study of RAD001 for Treatment of NF2-related Vestibular SchwannomaTerminatedNCT01345136Phase 2
- A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis PatientsTerminatedNCT01342016Phase 3
- Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven TumorsStatus unknownNCT01341834Phase 1
- Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor RemovalTerminatedNCT01341496Phase 1
- THAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM)CompletedNCT01341262Phase 2
- Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT)Status unknownNCT01339988Phase 4
- Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic MelanomaCompletedNCT01339663Phase 1
- A Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver TransplantationCompletedNCT01339468Phase 4
- Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Untreated Diffuse Large B-Cell LymphomaCompletedNCT01334502Phase 1
- Comparison of Medication Adherence Between Once and Twice Daily Tacrolimus in Stable Renal Transplant RecipientsCompletedNCT01334333Phase 4
- Study of the Combination of Axitinib Plus Everolimus in Patients With Malignant Advanced Solid TumorsCompletedNCT01334073Phase 1
- Impact of Subcutaneous Abatacept in Rheumatoid Arthritis Assessing Inhibition of Structural DamageCompletedNCT01333878Phase 2/3
- Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult VitiligoStatus unknownNCT01333410Phase 4
- Everolimus, Carboplatin, and Paclitaxel in Locally Advanced Head and Neck Cancer That Cannot Be Removed by SurgeryCompletedNCT01333085Phase 1/2
- Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation TherapyWithdrawnNCT01332279Phase 1
- Study to Compare the Pharmacokinetics of Tacrolimus in Adult Transplant Recipients Treated With Advagraf® or Prograf®CompletedNCT01332201Phase 2
- Aflac ST0901 CHOANOME - Sirolimus in Solid TumorsCompletedNCT01331135Phase 1
- Feasibility Study of Metronomic Chemotherapy for Locally Advanced HER2-Negative Breast CancerTerminatedNCT01329627Phase 2
- Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Treatment in Refractory Lupus NephritisCompletedNCT01328834Phase 3
- A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia GravisCompletedNCT01325571Phase 3
- Safety and Efficacy of RAD001 in Chinese Patients With Advanced Pulmonary Neuroendocrine TumorCompletedNCT01324492Phase 1
- Bevacizumab and Trastuzumab With Weekly Paclitaxel Followed, After Surgery, by Encapsuled Liposomal Doxorubicin, Cyclophosphamide and Trastuzumab as Adjuvant Treatment After Surgery on Women With Her2+ Breast CancerStatus unknownNCT01321775Phase 2
- A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis PatientsTerminatedNCT01316133Phase 4
- Abatacept Treatment in Polymyositis and DermatomyositisCompletedNCT01315938Phase 2
- Abatacept Costimulatory Blockade in the Treatment of Alopecia Totalis/UniversalisWithdrawnNCT01314495Phase 2
- Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or MediastinumTerminatedNCT01313429Phase 1
- Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck CancerTerminatedNCT01313390Phase 1/2
- De Novo Everolimus-based Therapy for Renal Transplantation Using Rituximab InductionTerminatedNCT01312064Phase 4
- Biomarker Study After Initiation of Treatment With Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple SclerosisCompletedNCT01310166Phase 4
- The Efficacy and Tolerance of Tacrolimus Sustained-release Capsules on Refractory Nephrotic Syndrome (RNS)CompletedNCT01309477Phase 3
- Strategies To Prevent Cardiac Allograft Vasculopathy Related Events in Heart Transplant RecipientsWithdrawnNCT01305395Not applicable